Enterprises ImportFab Inc. has been acquired by Labomar S.p.A
October 2019 — Labomar S.p.A., a leading company in the research, development and production of food supplements, medical devices and foods for specific medical and cosmetic purposes, has acquired Enterprises ImportFab Inc., a Canadian firm based in Montréal that operates in the North American pharmaceutical, cosmetic and nutraceutical market. The operation has been carried out in partnership with SIMEST that will participate in the acquisition and will hold a minority share of the Canadian company.
ImportFab is a well-established contract manufacturer, specializing in the manufacturing and packaging of semi-solid and liquid products for the pharmaceutical, cosmetic and nutraceutical market. With 30 years of experience, the company has a very strong customer base. ImportFab is accredited by Health Canada and the US FDA.
Headquartered in Italy, Labomar is a reliable partner with over twenty years experience offering its customers effective, quality, front-line solutions in the field of food supplements, medical devices, cosmetics, as well as foods for special medical purposes. Labomar is engaged in production on behalf of third parties, providing a complete service ranging from selection of the raw materials to delivery of the finished product. The heart and soul of its activity is the research and development department, guaranteeing constant innovation and quality.
Our role in the transaction
Oaklins' team in Canada advised the seller, contacted over 100 potential buyers through its international teams and negotiated the terms of the transaction. Oaklins' team in Italy introduced Labomar and assisted throughout the process.
Sylvain Renzi
Founder, Enterprises ImportFab, Inc.
Talk to the deal team
Related deals
Cibus has acquired Aweta from Standard Investment
Standard Investment has reached an agreement with Cibus Capital, advisor to the Cibus funds, on the sale of Aweta, a global leader in fruit and vegetable sorting, grading and packing equipment. Completion of the transaction is expected in the coming weeks. The transaction provides Aweta with a strong partner to support the company’s next growth phase. Under Cibus’ ownership, Aweta will pursue further international growth and accelerate investment in R&D, supporting the installed base and product innovation, including software and AI capabilities. Aweta’s leadership team will continue to lead the business.
Learn moreComtax has been acquired by Ryan
Comtax, a São Paulo-based tax technology consultancy specializing in tax determination and digital tax compliance, had been acquired by Ryan, the world’s largest firm dedicated exclusively to business taxes. The transaction marks Ryan’s entry into the Brazilian market, adding a specialized team and an established base of large corporate clients in Brazil, one of the world’s most complex tax environments, at a time when the country’s consumption tax reform is set to reshape how companies calculate and report indirect taxes. For Comtax, the acquisition brings access to Ryan’s global platform, technology and client network across more than 80 countries, creating opportunities to scale its tax determination and compliance offering beyond its current footprint. Comtax’s founders will continue to lead the business.
Learn moreKatalyst Diagnostics has been acquired by Cruinn Diagnostics
Katalyst Diagnostics Ltd. has been acquired by Cruinn Diagnostics Ltd. The acquisition strengthens Cruinn Diagnostics’ presence in the UK diagnostics market, adding established NHS customer relationships, local commercial infrastructure and a complementary portfolio of point-of-care diagnostic solutions. It also creates opportunities to introduce Cruinn Diagnostics’ products to UK customers while leveraging its established Irish platform to accelerate the growth of Katalyst Diagnostics’ portfolio in Ireland. With more than 100 employees and revenues in excess of US$56 million, the combined business will continue to focus on the UK market, where Cruinn Diagnostics sees significant opportunities to expand through further investment and targeted M&A.
Learn more